Aminoglycosides
"Aminoglycosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
Descriptor ID |
D000617
|
MeSH Number(s) |
D09.408.051
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aminoglycosides".
Below are MeSH descriptors whose meaning is more specific than "Aminoglycosides".
This graph shows the total number of publications written about "Aminoglycosides" by people in this website by year, and whether "Aminoglycosides" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 0 | 1 | 1 | 1981 | 0 | 1 | 1 | 1983 | 0 | 1 | 1 | 1984 | 0 | 1 | 1 | 1985 | 0 | 1 | 1 | 1987 | 0 | 1 | 1 | 1994 | 0 | 1 | 1 | 1997 | 0 | 1 | 1 | 2002 | 0 | 1 | 1 | 2013 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Aminoglycosides" by people in Profiles.
-
Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013 Sep; 13(9):785-96.
-
Barrack RL, Berend KR, Cui Q, Fehring TK, Della Valle CJ, Gehrke T, Lombardi AV, Mont MA, Parvizi J, Springer BD. Cement spacers in periprosthetic joint infection. Clin Infect Dis. 2013 Jul; 57(2):328-9.
-
Banan A, Fields JZ, Farhadi A, Talmage DA, Zhang L, Keshavarzian A. Activation of delta-isoform of protein kinase C is required for oxidant-induced disruption of both the microtubule cytoskeleton and permeability barrier of intestinal epithelia. J Pharmacol Exp Ther. 2002 Oct; 303(1):17-28.
-
Fischer SA, Trenholme GM, Costanzo MR, Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis. 1997 Jan; 24(1):18-23.
-
Hayden MK, Harris AA. Confronting antibiotic resistance in enterococcal infections. Contemp Intern Med. 1994 Sep; 6(9):7-17.
-
Weinstein RA, Nathan C, Delzell D, Kabins SA. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics. Chemioterapia. 1987 Oct; 6(5):315-8.
-
Olson B, Weinstein RA, Nathan C, Chamberlin W, Kabins SA. Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control. J Infect Dis. 1985 Oct; 152(4):769-74.
-
Levin MH, Olson B, Nathan C, Kabins SA, Weinstein RA. Pseudomonas in the sinks in an intensive care unit: relation to patients. J Clin Pathol. 1984 Apr; 37(4):424-7.
-
Gaynes RP, Weinstein RA, Smith J, Carman M, Kabins SA. Control of aminoglycoside resistance by barrier precautions. Infect Control. 1983 Jul-Aug; 4(4):221-4.
-
Weinstein RA, Kabins SA. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med. 1981 Feb; 70(2):449-54.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|